Received Mar 24, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPA | HEP A (HAVRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | — | IM / RL |
| HIBV | HIB (PEDVAXHIB) | MERCK & CO. INC. | 1 | — | IM / RL |
| PNC20 | PNEUMO (PREVNAR20) | PFIZER\WYETH | 1 | — | IM / LL |
| TDAP | TDAP (BOOSTRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | — | IM / LL |
Patient is 2 YO and was given a dose of Tdap. that was incorrect and he should have been administered Dtap. No injuries or adverse reactions. Patient will have to repeat a dose of Dtap at his next well child visit to get back on schedule.
n/a
n/a
n/a
NKA
n/a